Glenmark Pharma reported Rs 340 crore net profit in Q2FY25 led by robust sales growth in India and Europe. The drugmaker reported a net loss of Rs 180 crore in …
Glenmark Pharma surged 8% to a day’s high of Rs 1,763.90 on BSE after the United States Food & Drug Administration’s (USFDA) Good Manufacturing Practice (GMP) inspection at its Aurangabad …
Domestic markets edged higher on Friday, gaining nearly one and a half percent, largely tracking global trends. In today’s trade, shares of SpiceJet, Mankind Pharma, Vodafone Idea, Aarti Drugs, BHEL, …
Domestic markets remained lackluster and closed flat on Wednesday, taking a pause after Tuesday’s decline. In today’s trade, shares of Ola Electric, Hindustan Zinc, SpiceJet, SBI, Glenmark Pharma among others …
Domestic markets settled at record high levels in their third straight day of gains on Tuesday. In today’s trade, Infosys, Tata Technologies, Asian Paints, Nazara Technologies, Adani Green among others …
Markets fluctuated sharply within a range and ended up losing nearly half a percent on Wednesday, wiping out the gains from the preceding session. In today’s trade, shares of Nykaa, …
Promising trials of a new antibiotic drug trademarked as Zaynich – meant to act against all major superbugs – has triggered a sharp run-up in the Wockhardt stock. It has …
Indian market is expected to trade higher on Tuesday tracking positive global cues. The Nifty50 closed below 22400 levels on Monday led by losses in banking stocks. It has formed …
Mumbai: The earnings upgrade-to-downgrade ratio has weakened over the past three months, with 251 companies in the Nifty 500 universe experiencing downgrades for FY24, compared with 152 upgrades, Bloomberg data …
Indian headline indices hit fresh lifetime highs on Friday ending with weekly gains of 2.7% on a dovish pivot by the US Fed. The biggest gainers were IT and bank …